Myokardiale vitalitätsdiagnostik. Rolle der nuklearkardiologie und der magnetresonanztomographie

Translated title of the contribution: Myocardial viability assessment. The roll of nuclear medicine and magnetic resonance imaging

F. M. Bengel

Research output: Contribution to journalReview articlepeer-review

Abstract

The diagnosis of myocardial vitality is used for patients with advanced coronary heart disease and heart failure in order to identify candidates for revascularising procedures. The basic principle is the differentiation between ischemically compromised but still viable myocardium (hibernating myocardium) and non-viable scar tissue. Nuclear cardiac procedures, especially positron emission tomography (PET), play a primary role in establishing this diagnosis. PET is still seen as the gold standard. Magnetic resonance imaging is a more recent and increasingly popular procedure due to its estimation of viability through excellent spatial clarity. In this review, the basic principles and data base for both procedures are discussed for this specific indication.

Translated title of the contributionMyocardial viability assessment. The roll of nuclear medicine and magnetic resonance imaging
Original languageGerman
Pages (from-to)45-54
Number of pages10
JournalClinical Research in Cardiology Supplements
Volume2
Issue number1
DOIs
StatePublished - Dec 1 2007

Keywords

  • Heart failure
  • MRI
  • Myocardiac viability
  • Nuclear cardiology
  • PET

ASJC Scopus subject areas

  • Structural Biology
  • Molecular Biology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Myocardial viability assessment. The roll of nuclear medicine and magnetic resonance imaging'. Together they form a unique fingerprint.

Cite this